124 related articles for article (PubMed ID: 33405434)
21. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: Impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy.
DeWitt J; Kesler K; Brooks JA; LeBlanc J; McHenry L; McGreevy K; Sherman S
Dis Esophagus; 2005; 18(1):21-7. PubMed ID: 15773837
[TBL] [Abstract][Full Text] [Related]
23. Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study.
Verbeek RE; Leenders M; Ten Kate FJ; van Hillegersberg R; Vleggaar FP; van Baal JW; van Oijen MG; Siersema PD
Am J Gastroenterol; 2014 Aug; 109(8):1215-22. PubMed ID: 24980881
[TBL] [Abstract][Full Text] [Related]
24. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
[TBL] [Abstract][Full Text] [Related]
25. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
[TBL] [Abstract][Full Text] [Related]
26. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
27. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?
Luu C; Amaral M; Klapman J; Harris C; Almhanna K; Hoffe S; Frakes J; Pimiento JM; Fontaine JP
World J Gastroenterol; 2017 Dec; 23(46):8193-8199. PubMed ID: 29290655
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.
Moss A; Bourke MJ; Hourigan LF; Gupta S; Williams SJ; Tran K; Swan MP; Hopper AD; Kwan V; Bailey AA
Am J Gastroenterol; 2010 Jun; 105(6):1276-83. PubMed ID: 20179694
[TBL] [Abstract][Full Text] [Related]
30. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
[TBL] [Abstract][Full Text] [Related]
31. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
[TBL] [Abstract][Full Text] [Related]
32. Clinical prediction model for tumor progression in Barrett's esophagus.
Holmberg D; Ness-Jensen E; Mattsson F; Lagergren J
Surg Endosc; 2019 Sep; 33(9):2901-2908. PubMed ID: 30456503
[TBL] [Abstract][Full Text] [Related]
33. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
[TBL] [Abstract][Full Text] [Related]
34. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy.
Abdel-Latif MM; O'Riordan J; Windle HJ; Carton E; Ravi N; Kelleher D; Reynolds JV
Ann Surg; 2004 Apr; 239(4):491-500. PubMed ID: 15024310
[TBL] [Abstract][Full Text] [Related]
35. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus.
El-Serag HB; Naik AD; Duan Z; Shakhatreh M; Helm A; Pathak A; Hinojosa-Lindsey M; Hou J; Nguyen T; Chen J; Kramer JR
Gut; 2016 Aug; 65(8):1252-60. PubMed ID: 26311716
[TBL] [Abstract][Full Text] [Related]
36. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Kukar M; Alnaji RM; Jabi F; Platz TA; Attwood K; Nava H; Ben-David K; Mattson D; Salerno K; Malhotra U; Kanehira K; Gannon J; Hochwald SN
JAMA Surg; 2015 Jun; 150(6):555-62. PubMed ID: 25902198
[TBL] [Abstract][Full Text] [Related]
37. EUS in the management of the patient with dysplasia in Barrett's esophagus.
Savoy AD; Wallace MB
J Clin Gastroenterol; 2005 Apr; 39(4):263-7. PubMed ID: 15758616
[TBL] [Abstract][Full Text] [Related]
38. Preoperative evaluation of oesophageal adenocarcinoma.
Khanna LG; Gress FG
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):179-91. PubMed ID: 25743465
[TBL] [Abstract][Full Text] [Related]
39. Results of a multimodal therapy in patients with stage IV Barrett's adenocarcinoma.
Schauer M; Stein H; Lordick F; Feith M; Theisen J; Siewert JR
World J Surg; 2008 Dec; 32(12):2655-60. PubMed ID: 18802733
[TBL] [Abstract][Full Text] [Related]
40. Influence of treatment modality in outcomes for different stages of resectable esophageal adenocarcinomas.
Allan BJ; Pedroso F; Gennis ER; Livingstone AS; Montero A; Lally B; Ardalan B; Koniaris LG; Solomon NL; Franceschi D
Ann Surg Oncol; 2013 May; 20(5):1660-7. PubMed ID: 23456314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
